Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:17:91-5.
doi: 10.1007/8904_2014_343. Epub 2014 Oct 12.

Improvement of Cardiomyopathy After High-Fat Diet in Two Siblings with Glycogen Storage Disease Type III

Affiliations

Improvement of Cardiomyopathy After High-Fat Diet in Two Siblings with Glycogen Storage Disease Type III

Alessandra Brambilla et al. JIMD Rep. 2014.

Abstract

Glycogenosis type III (GSD III) is an autosomal recessive disorder due to amylo-1,6-glucosidase deficiency. This disease causes limit dextrin storage in affected tissues: liver, skeletal muscles, and heart in GSD IIIa and only liver in GSD IIIb. Cardiomyopathy is quite frequent in GSD IIIa with variable severity and progression of manifestations. It is not clear if diet manipulation may interfere with cardiomyopathy's progression. Recent case reports showed improvement of cardiomyopathy following a ketogenic diet.Two siblings (girl and boy), 7- and 5-year-old, both affected with GSD IIIa, developed severe and rapidly worsening left ventricular hypertrophy in the first years of life, while treated with frequent diurnal and nocturnal hyperproteic meals followed by orally administered uncooked cornstarch. Subsequently they were treated with high-fat (60%) and high-protein (25%), low-carbohydrate (15%) diet. After 12 months exertion dyspnea disappeared in the girl and biochemical blood tests, cardiac enzymes, and congestive heart failure markers improved in both (CK 3439→324, 1304→581 U/L; NT-proBNP 2084→206, 782→135 pg/mL, respectively); ultrasound assessment in both patients showed a relevant reduction of the thickness of interventricular septum (30→16, 16→11 mm, respectively) and left ventricle posterior wall (18→7, 13→8 mm, respectively) and an improvement of the outflow obstruction. A diet rich in fats as well as proteins and poor in carbohydrates could be a beneficial therapeutic choice for GSD III with cardiomyopathy. Future research is needed to confirm the beneficial effect of this treatment and to design treatment strategies with the aim to provide alternative source of energy and prevent glycogen accumulation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
2D and M-mode echocardiography of girl (1-A and 2-A) and boy (1-B and 2-B) before and after the diet manipulation. IVS interventricular septum, PW posterior wall of the left ventricle. Note the typical systolic anterior motion of the mitral valve (SAM), responsible of outflow obstruction (asterisk) and the reduction of the thickness and the amplitude of SAM after the diet

References

    1. Austin SL, Proia AD, Spencer-Manzon MJ, Butany J, Wechsler SB, Kishnani PS. Cardiac pathology in glycogen storage disease type III. JIMD Rep. 2012;6:65–72. doi: 10.1007/8904_2011_118. - DOI - PMC - PubMed
    1. Dagli AI, Zori RT, McCune H, Ivsic T, Maisenbacher MK, Weinstein DA. Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet. J Inherit Metab Dis Suppl. 2009;32(Suppl 1):S103–106. doi: 10.1007/s10545-009-1088-x. - DOI - PMC - PubMed
    1. Fuehrlein BS, Rutemberg MS, Silver JN, et al. Differential metabolic effects of saturated versus polyunsaturated fats in ketogenic diets. J Clin Endocrinol Metab. 2004;89:1641–1645. doi: 10.1210/jc.2003-031796. - DOI - PubMed
    1. Kishnani PS, Austin SL, Arn P, et al. Glycogen storage disease type III diagnosis and management guidelines. Genet Med. 2010;12:446–463. doi: 10.1097/GIM.0b013e3181e655b6. - DOI - PubMed
    1. Sentner CP, Calistan K, Vletter WB, Smit GPA. Heart failure due to severe hypertrophic cardiomyopathy reversed by low calorie, high protein dietary adjustments in a Glycogen Storage Disease type IIIa patient. JIMD Rep. 2012;5:13–16. doi: 10.1007/8904_2011_111. - DOI - PMC - PubMed

LinkOut - more resources